Literature DB >> 20688875

Effects of statins on skeletal muscle: a perspective for physical therapists.

Stephanie L Di Stasi1, Toran D MacLeod, Joshua D Winters, Stuart A Binder-Macleod.   

Abstract

Hyperlipidemia, also known as high blood cholesterol, is a cardiovascular health risk that affects more than one third of adults in the United States. Statins are commonly prescribed and successful lipid-lowering medications that reduce the risks associated with cardiovascular disease. The side effects most commonly associated with statin use involve muscle cramping, soreness, fatigue, weakness, and, in rare cases, rapid muscle breakdown that can lead to death. Often, these side effects can become apparent during or after strenuous bouts of exercise. Although the mechanisms by which statins affect muscle performance are not entirely understood, recent research has identified some common causative factors. As musculoskeletal and exercise specialists, physical therapists have a unique opportunity to identify adverse effects related to statin use. The purposes of this perspective article are: (1) to review the metabolism and mechanisms of actions of statins, (2) to discuss the effects of statins on skeletal muscle function, (3) to detail the clinical presentation of statin-induced myopathies, (4) to outline the testing used to diagnose statin-induced myopathies, and (5) to introduce a role for the physical therapist for the screening and detection of suspected statin-induced skeletal muscle myopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688875      PMCID: PMC2949584          DOI: 10.2522/ptj.20090251

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  73 in total

1.  Discontinuation of statin treatment in stroke patients.

Authors:  Matthias Endres; Ulrich Laufs
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

2.  Elevated skeletal muscle phosphodiesters in adults using statin medications.

Authors:  Jill M Slade; Mark C Delano; Ronald A Meyer
Journal:  Muscle Nerve       Date:  2006-12       Impact factor: 3.217

Review 3.  Rabs and their effectors: achieving specificity in membrane traffic.

Authors:  Bianka L Grosshans; Darinel Ortiz; Peter Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

4.  Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation.

Authors:  N M Fisher; K Meksawan; A Limprasertkul; P J Isackson; D R Pendergast; G D Vladutiu
Journal:  J Inherit Metab Dis       Date:  2007-04-05       Impact factor: 4.982

5.  Respiratory gas-exchange ratios during graded exercise in fed and fasted trained and untrained men.

Authors:  B C Bergman; G A Brooks
Journal:  J Appl Physiol (1985)       Date:  1999-02

Review 6.  Statin-induced myopathy: the two faces of Janus.

Authors:  Rohit Arora; Max Liebo; Frank Maldonado
Journal:  J Cardiovasc Pharmacol Ther       Date:  2006-06       Impact factor: 2.457

Review 7.  Statin-induced apoptosis and skeletal myopathy.

Authors:  Amie J Dirks; Kimberly M Jones
Journal:  Am J Physiol Cell Physiol       Date:  2006-08-02       Impact factor: 4.249

8.  Serum creatine kinase levels and renal function measures in exertional muscle damage.

Authors:  Priscilla M Clarkson; Amy K Kearns; Pierre Rouzier; Richard Rubin; Paul D Thompson
Journal:  Med Sci Sports Exerc       Date:  2006-04       Impact factor: 5.411

Review 9.  Clinical perspectives of statin-induced rhabdomyolysis.

Authors:  Kenneth A Antons; Craig D Williams; Steven K Baker; Paul S Phillips
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

10.  Genetic determinants of statin intolerance.

Authors:  Jisun Oh; Matthew R Ban; Brooke A Miskie; Rebecca L Pollex; Robert A Hegele
Journal:  Lipids Health Dis       Date:  2007-03-21       Impact factor: 3.876

View more
  24 in total

1.  The relationship between school performance and the number of physical education classes attended by korean adolescent students.

Authors:  Sang-Yeob Kim; Wi-Young So
Journal:  J Sports Sci Med       Date:  2012-06-01       Impact factor: 2.988

2.  Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Authors:  Dominic Mitchell; Jason R Guertin; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

3.  A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Authors:  Dominic Mitchell; Jason R Guertin; Anick Dubois; Marie-Pierre Dubé; Jean-Claude Tardif; Ange Christelle Iliza; Fiorella Fanton-Aita; Alexis Matteau; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

Review 4.  Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.

Authors:  Roli B Iwere; Jonathan Hewitt
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

Review 5.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

6.  Synergistic interaction between genetics and disease on pravastatin disposition.

Authors:  John D Clarke; Rhiannon N Hardwick; April D Lake; Andrew J Lickteig; Michael J Goedken; Curtis D Klaassen; Nathan J Cherrington
Journal:  J Hepatol       Date:  2014-03-05       Impact factor: 25.083

7.  Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure.

Authors:  Danielle L Brunjes; Mark Dunlop; Christina Wu; Meaghan Jones; Tomoko S Kato; Peter J Kennel; Hilary F Armstrong; Tse-Hwei Choo; Matthew N Bartels; Daniel E Forman; Donna M Mancini; P Christian Schulze
Journal:  J Card Fail       Date:  2016-02-12       Impact factor: 5.712

8.  Statin-induced rhabdomyolysis: a comprehensive review of case reports.

Authors:  Polyana Mendes; Priscila Games Robles; Sunita Mathur
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

9.  Prevalence of musculoskeletal pain in association with serum 25-hydroxyvitamin D concentrations in patients with type 2 diabetes mellitus.

Authors:  Mohammad J Alkhatatbeh; Khalid K Abdul-Razzak; Lubna Q Khasawneh; Nesreen A Saadeh
Journal:  Biomed Rep       Date:  2018-04-26

10.  Alterations in zebrafish development induced by simvastatin: Comprehensive morphological and physiological study, focusing on muscle.

Authors:  Laise M Campos; Eduardo A Rios; Livia Guapyassu; Victor Midlej; Georgia C Atella; Suzana Herculano-Houzel; Marlene Benchimol; Claudia Mermelstein; Manoel L Costa
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.